Moderna para Covid-19 vaccine mRNA-1273 bona soru

Washington: October 30, 2020. American biotechnology company Moderna para duniyaa nemite Covid-19 vaccine candidate bona soru hoishe koikena junaishe. “ami khan besi bhal para mRNA-1273 bonai ase aro government logot duniyaa sob te supply thiboli nemite signed korishe. Etu khobor toh Moderna CEO Stephane Bancel para kowa Xinhua news agency para Thursday din statement te janaishe. Etu oper te Covid-19 vaccine mRNA-1273 laga Phase 3 study toh sob nam thalikena ase. Moderna toh Phase 2 studies te 4 programs ase, Bancel para koishe. “”Moderna para sobse bhal data quality standards thiboli wada thishe aro scientific research nemite narokina mRNA-1273 toh agae te loijaboli kam koribo” tai aro koishe. October 22 darik te, mRNA-1273 laga Phase 3 study te 30,000 manuh laga nam thala toh kotom hoishe aro 37 per cent neshina manuh khan alag-alag chaka para ase koishe. Vaccine laga Phase 1 interim analysis toh July 14 darik New England Journal of Medicine te olaishe, aro etu samai mRNA-1273 toh manuh sob laga umer group te besi bhal para kam hoishe aro SARS-CoV-2 kelaaf te tangor aro tankot thakina immune jawab thikaishe koishe.